Solium Capital is undervalued, says Haywood

Following the company’s fourth quarter results, Haywood analyst Pardeep Sangha is feeling bullish about Solium Capital (Solium Capital Stock Quote, Chart, News: TSX:SUM).

Yesterday, Solium reported its Q4 and fiscal 2016 results. In the fourth quarter, the company posted Adjusted EBITDA of $2.55-million on revenue of $18.87-million, a topline that was up 11.7 per cent over the same period last year.

Sangha says Solium’s revenue number came in below his estimate of $19.4-million, but notes that it handily beat his EBITDA estimate of $1.8-million.

“Revenue was positively impacted by an increase in transactional revenue and growth in the Canadian market, explains the analyst. “Transactional-based revenue increased by $2.5M in Q4FY16, or 13% as compared to Q4FY15. Revenue in Canada was up 9.4 % in the full year due to increased transactional activity.

Sangha says the impact of the quarter was mixed, and explained why in a research update to clients today.

“Despite announcing the large Morgan Stanley deal in Q4, Solium will experience EBITDA margin pressures in FY17 as it ramps up to support this contract,” he said.

The analyst says this is the reason that despite the better bottom line numbers, he today maintained his one-year target of $9.70 and “Buy” rating on Solium. His target implied a return of 20.2 per cent at the time of publication.

Sangha thinks Solium will generate Adjusted EBITDA of $12.0-million on revenue o $85.8-million in fiscal 2017. He expects these numbers will improve to EBITDA of $18.9-million on a topline of $104.9-million the following year.

More Cantech Software

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

4 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

4 days ago